Amgen Executive and Leadership Team

Carlos Mauricio, the Chief Financial Officer at Amgen, directs the financial strategy and operations for the company. This leadership role involves managing Amgen's global financial health, ensuring fiscal responsibility, and driving profitability. Mauricio oversees all accounting, financial planning, and analysis functions, providing critical insights to support strategic decision-making. The Chief Financial Officer's responsibilities extend to capital allocation, investor relations, and risk management, safeguarding Amgen's financial stability and growth trajectory. By optimizing financial resources, Carlos Mauricio directly contributes to the company's mission of delivering innovative therapies to patients worldwide. This executive ensures robust financial controls and compliance across all operational segments.

Peter Griffith, the Executive VP & Chief Financial Officer at Amgen, holds ultimate responsibility for the company's financial health and strategic fiscal direction. This senior leadership position involves overseeing all aspects of financial management, including budgeting, forecasting, and capital markets activities. Griffith directs the global finance organization, ensuring robust financial controls and compliance with regulatory requirements. The Executive VP & Chief Financial Officer plays a pivotal role in shaping Amgen's long-term financial strategy, driving investments in research and development, and maximizing shareholder value. Peter Griffith's leadership ensures Amgen maintains a strong financial foundation to support its mission of developing innovative medicines. This executive guides financial planning for global operations and strategic acquisitions.

Konosuke Sasaki, the Head Chief Financial Officer, Country of Alliance & Director, Bd, Board of Amgen (Japan) at Amgen, leads financial operations and governance within the Japanese market and alliance countries. This critical role involves managing financial strategy, ensuring compliance, and driving fiscal performance in a key international region. Sasaki oversees all financial activities, including accounting, reporting, and strategic financial planning, tailored to the specific market dynamics of Japan and allied regions. As a Director on the Board of Amgen (Japan), Konosuke Sasaki provides crucial financial oversight and strategic guidance, contributing to the company's governance and long-term success in the region. This executive's expertise ensures Amgen's financial integrity and operational effectiveness in its international ventures.

Carlos Collado, the Chief Financial Officer, Country & LATAM Distributors (Mexico) at Amgen, spearheads financial strategy and management for Mexico and the broader Latin American distributor network. This executive role involves overseeing financial operations, ensuring fiscal discipline, and driving revenue growth across the region. Collado manages budgeting, financial reporting, and compliance for Amgen's activities in Mexico, working closely with local distributors to optimize financial performance. The Chief Financial Officer, Country & LATAM Distributors (Mexico) provides essential financial insights to support market expansion and strategic partnerships within Latin America. Carlos Collado's financial acumen is vital for Amgen's success in these key emerging markets.

Marianela Capelli, the Chief Financial Officer (Argentina) at Amgen, manages the financial operations and strategic fiscal planning for Amgen's activities within Argentina. This role is essential for ensuring financial health, compliance, and growth in the Argentine market. Capelli oversees all financial functions, including accounting, budgeting, and financial analysis, providing critical insights to support local business objectives. The Chief Financial Officer (Argentina) works to optimize financial performance and resource allocation, contributing directly to Amgen's mission of delivering innovative therapies. Marianela Capelli's financial leadership ensures Amgen's sustained success and operational integrity within Argentina.

Stoyan Mihnev, the Project Manager & Chief of Staff at Amgen, orchestrates critical projects and provides strategic support to senior leadership. This dual role demands meticulous planning and execution of key initiatives, ensuring alignment with Amgen's overarching business objectives. Mihnev manages cross-functional project teams, driving progress and mitigating risks to deliver successful outcomes. As Chief of Staff, Stoyan Mihnev facilitates communication and operational efficiency across departments, acting as a key liaison between various leadership functions. This executive's focus on operational excellence and strategic project delivery is vital for advancing Amgen's pipeline and market presence. The Project Manager & Chief of Staff ensures seamless integration of new strategies and operational enhancements.

Katherine Rizos, the Director, Strategic Planning & Operations & To The Chief of Staff & Chief Information Officer at Amgen, drives critical strategic initiatives and operational enhancements. This multifaceted role involves developing and implementing long-term strategic plans that align with Amgen's scientific and business goals. Rizos oversees operational efficiency, ensuring seamless execution of key projects and programs. As a key advisor to the Chief of Staff and Chief Information Officer, Katherine Rizos provides essential insights into technology strategy and operational integration. The Director, Strategic Planning & Operations ensures that Amgen's operational framework supports its innovation pipeline and global market expansion. This executive's work directly impacts Amgen's ability to bring life-changing therapies to patients.

Adrian Sparrow, the Global Corporate Affairs Chief of Staff at Amgen, directs strategic initiatives and operational efficiency within the corporate affairs division. This role is central to coordinating global communications, public relations, and government affairs efforts, ensuring alignment with Amgen's corporate mission. Sparrow manages cross-functional projects and provides critical support to the head of Global Corporate Affairs, enhancing strategic execution and stakeholder engagement. The Global Corporate Affairs Chief of Staff ensures seamless integration of corporate messaging and policy initiatives across all international markets. Adrian Sparrow's leadership strengthens Amgen's reputation and its ability to navigate complex regulatory and public landscapes, supporting the delivery of innovative therapies.

Scott Skellenger, the Senior Vice President and Chief Information Officer at Amgen, directs the company's global information technology strategy and operations. This leadership position is crucial for enabling scientific innovation and operational efficiency through advanced technological solutions. Skellenger oversees all aspects of IT infrastructure, cybersecurity, data management, and digital transformation initiatives. The Senior Vice President and Chief Information Officer ensures that Amgen's technology platforms support its research, development, manufacturing, and commercialization efforts worldwide. Scott Skellenger's strategic vision drives the adoption of cutting-edge technologies, enhancing Amgen's competitive edge and its ability to deliver life-changing medicines to patients globally.

Patrick Hylton, the Chief of Staff, Oncology (US) at Amgen, drives strategic execution and operational alignment within the US Oncology division. This key role supports the leadership of Amgen's oncology business, ensuring seamless coordination of critical initiatives and projects. Hylton manages cross-functional efforts, facilitating communication and collaboration among research, development, and commercial teams focused on cancer therapies. The Chief of Staff, Oncology (US) plays an integral part in advancing Amgen's pipeline and market strategies for oncology treatments. Patrick Hylton's operational expertise enhances the division's ability to bring life-saving innovations to patients across the United States.